PrimeVax Immuno-Oncology Competitors and Similar CompaniesClear all
PrimeVax Immuno-Oncology's competitors and similar companies include Catapult Therapeutics, immunoSCAPE, Ossium Health and Kuur Therapeutics.
 PrimeVax Immuno-Oncology PrimeVax Immuno-Oncology is a company that develops a multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens. |  Catapult Therapeutics Catapult Therapeutics is a biotech company developing CAP-100, a humanized anti-CCR7 antibody. |  immunoSCAPE immunoSCAPE is a company that measures treatment and outcome-associated changes in antigen-specific T cells and patient immune response. |  Ossium Health Ossium Health is a company building bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation. |  Kuur Therapeutics Kuur Therapeutics (formerly known as Cell Medica) is a company that develops CAR-NKT cell therapy to treat cancer. | |
Founding Date | Founding Date 2015 | Founding Date 2015 | Founding Date 2016 | Founding Date 2016 | Founding Date 2020 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Orange, US HQ | Locations Lelystad, NL HQ 's Hertogenbosch, NL | Locations Singapore, SG HQ Nucleos, SG Cambridge, US San Diego, US | Locations San Francisco, US HQ Indianapolis, US | Locations London, GB HQ |
Employees | Employees 7 | Employees 5 | Employees 329% decrease | Employees 89 | Employees 9 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 14m (about 5 years ago) | Latest funding round $ 63m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 24.9m | Total funding raised $ 73.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Catapult Therapeutics
HQ
Lelystad, NL
Employees
5
Catapult Therapeutics is a biotech company developing CAP-100, a humanized anti-CCR7 antibody.
View companyimmunoSCAPE
HQ
Singapore, SG
Employees
32↓ 9% decrease
immunoSCAPE is a company that measures treatment and outcome-associated changes in antigen-specific T cells and patient immune response.
View companyOssium Health
HQ
San Francisco, US
Employees
89
Ossium Health is a company building bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.
View companyKuur Therapeutics
HQ
London, GB
Employees
9
Kuur Therapeutics (formerly known as Cell Medica) is a company that develops CAR-NKT cell therapy to treat cancer.
View company